Abstract
Patients with atopic dermatitis have high rates of skin surface colonization of Staphylococcus aureus. At the same time, S. aureus is the major causative organism in infective endocarditis, approximately accounting for 30%~50% cases of infective endocarditis. A 22-year-old male with severe atopic dermatitis presented with fever and myalgia. He was diagnosed with active infective endocarditis causing multiple cerebral infarction, splenic infarction, and septic shoulder requiring synovectomy. Blood culture proved methicillinsensitive Staphylococcus aureus bacteremia, and the culture from the skin revealed same bacteria. After treated with intravenous antibiotics for 6 weeks, patient was improved. Another 42-year-old female with severe atopic dermatitis who presented with fever and chilling was hospitalized due to acute infective endocarditis. She also had left flank pain and visual disturbance, due to splenic infarction and acute cerebral infarction, respectively. As blood culture revealed methicillin-sensitive Staphylococcus aureus bacteremia, she treated with intravenous antibiotics for 6 weeks. The route of entry of two patients was attributed to the patient eczematous scratching lesion of poorly controlled atopic dermatitis. Infective endocarditis can result in the context of acute deterioration of atopic dermatitis. Dermatologists need to pay attention to this risk and actively manage such conditions in order to decrease the risk of infective endocarditis arising from skin lesions in atopic patients. For these reasons, we herein report two cases of infective endocarditis in patients with atopic dermatitis.
Patients with atopic dermatitis have high rates of skin surface colonization of Staphylococcus aureus123. At the same time, S. aureus is the major causative organism in infective endocarditis, approximately accounting for 30%~50% cases of infective endocarditis4. Atopic dermatitis is a relatively common disease and its prevalence is increasing in Korea56. In atopic dermatitis, itching and scratching are common symptoms, resulting in infiltration of Staphylococcus aureus, which is frequently colonized in patients with atopic dermatitis due to weak skin barrier function7. There have been few reports of cases of infective endocarditis occurring in patients with atopic dermatitis considering the high prevalence of atopic dermatitis, thereby few studies have been conducted on the association between them. Given that atopic dermatitis is a common condition and infective endocarditis is a life-threatening disease, it is quite surprising that dermatologists have had little interest in this relationship.
A 22-year-old man presented to the emergency department with fever and generalized skin rash. He also complained of chest pain, bilateral visual disturbance, and abdominal pain. There was no previous history of heart disease, rheumatic fever, or dental procedure, and no specific familial history of heart disease or dermatologic disease. He had uncontrolled severe atopic dermatitis, and have been treated with prednisolone started with 20 mg/day for several weeks and changed to cyclosporine 200 mg/day for 6 months. He had extremely dry skin with lichenification with oozing on whole body, especially on upper extremities. He was transferred to division of infectious disease.
On physical examination, the body temperature was 39.1℃, pulse rate 120/min and blood pressure 100/50 mmHg. Osler nodes and splinter hemorrhage were observed on his hands (Fig. 1). Laboratory investigation revealed hemoglobin 16.4 g/d, white blood cell (WBC) 15,400/µl with 84.4% neutrophil count, platelets 299,000/µl, erythrocyte sedimentation rate (ESR) 51 mm/hr, C-reactive protein 358.53 mg/L, and total immunoglobulins E (IgE) 609 IU/ml. Urine analysis showed no demonstrable results, and chest X-ray was normal. 12 lead electrocardiogram (EKG) showed sinus tachycardia with features of left ventricular hypertrophy. Transthoracic echocardiogram showed 1.7×0.6 cm sized mitral valve vegetation (Fig. 2), with normal ejection fraction. Computed tomography (CT) scan of the brain was normal but magnetic resonance imaging (MRI) scan identified multiple cerebral infarction due to embolism. CT scan of the abdomen was performed due to abdominal pain, showing splenic infraction due to embolism. Shoulder pain developed, and MRI scan showed septic arthritis (Fig. 2). Patient was referred to orthopedics and received synovectomy surgery. Two sets of blood cultures grew methicillin-sensitive S. aureus and the culture from the skin grew S. aureus with same antimicrobial susceptibilities. The patient was commenced on intravenous nafcillin 0.5 g/6 hour and changed to vancomycin 1 g/12 hour due to side effect of nafcillin. After 6 weeks of intravenous antibiotics treatment, his condition improved and discharged.
A 42-year-old woman with atopic dermatitis presented to the emergency department with fever and skin rash. She was suffered from left flank pain and visual disturbance. There was no previous history of heart disease, rheumatic fever, or dental procedure, and no familial history of heart disease or dermatologic disease. She had lichenified skin lesion with oozing on trunk, but she have not been treated with her atopic dermatitis except application of moisturizer.
On examination, the body temperature was 38.6℃, pulse rate 83/min and blood pressure 110/70 mmHg. Laboratory investigation revealed hemoglobin 7.7 g/d, WBC 10,700/ µl with 78.5% neutrophil count, platelets 378,000/µl, ESR 26.4 mm/hr, C-reactive protein 115.80 mg/L, and total IgE >2,500 IU/mL. Urine analysis showed no demonstrable results, and chest X-ray was normal. 12 lead EKG showed no demonstrable finding. Transthoracic echocardiogram revealed hypermobile 0.6×0.8 cm sized mitral valve vegetation, with normal ejection fraction. MRI scan of the brain identified multiple cerebral infarction due to embolism (Fig. 1). CT scan of the abdomen showed acute pyelonephritis on left kidney and splenic infraction due to embolism (Fig. 2). Two sets of blood cultures grew methicillin-sensitive Staphylococcus aureus. The patient was treated with intravenous nafcillin 1 g/4 hour. After 6 weeks of intravenous antibiotics treatment, her condition improved and discharged.
S. aureus is one of the major strains responsible for 30%~50% of infective endocarditis, emerging as one of the most common causes of infective endocarditis4. Skin colonization of S. aureus is also common in patient with atopic dermatitis123. S. aureus may cause superficial skin infection in patient with atopic dermatitis, but it may also cause invasive systemic infection, and bacteremia caused by S. aureus may cause severe conditions such as infective endocarditis and septic arthritis8. Valve destruction or neurological complications are more common, especially when S. aureus is the causative organism of bacteremia9.
Although studies on the relevance of infective endocarditis and atopic dermatitis have been reported steadily in several case reports, there is very little controlled research on relevance. Several case reports are described in Table 11011121314151617. In one study18, it was found that 6.7% (8/120) of patients with infective endocarditis had previous history of atopic dermatitis. Among patients with infective endocarditis, the age at onset was lower in patients with atopic dermatitis. Moreover, those with atopic dermatitis as the underlying disease were significantly more like to have Methicillin sensitive S. aureus as the causative organism of endocarditis.
In contrast to the skin colonization in the general population, the higher colonization of S. aureus in patient with atopic dermatitis can be explained for several reasons. In atopic dermatitis, skin barrier function is impaired, making penetration of bacteria more easily to penetration7. Furthermore, in patients with atopic dermatitis, cathelicidin (LL-37) and beta-defensin2 (HBD-2), known as inflammation-induced antimicrobial, antifungal, and antiviral peptides, are reduced19. It may play a role in enhancing susceptibility to colonization of S. aureus. For these reasons, the risk of S. aureus infection increases in patient with atopic dermatitis.
Both of the patients in this report developed infective endocarditis in the absence of underlying disease, such as other specific heart disease, or dental treatment. In the first case, atopic dermatitis was severe and uncontrollable at the onset of infective endocarditis, and the patient was being treated with drugs including cyclosporine and methylprednisolone for atopic dermatitis. The use of these immunomodulators could be another risk factor for infective endocarditis, but the second case was an atopic patient who did not manage without special treatment. These cases with no specific underlying disease in these patients with uncontrolled atopic dermatitis may be able to reinforce the association between atopic dermatitis and infective endocarditis.
As in the case, infective endocarditis due to S. aureus is a serious condition that can cause serious side effects such as cerebral embolism, multiorgan embolism, and septic shoulder. In addition to cardiovascular complication, pulmonary complications such as pneumonia and ocular complications have also been reported in infective endocarditis of atopic dermatitis patients8. Considering the high prevalence of atopic dermatitis and the severity of infective endocarditis, strict control of atopic dermatitis is necessary. Active management of eczematous lesions and impaired skin barrier is needed, and topical or systemic antibiotics might be helpful for acute flare for a short time. In addition, immunosuppressants are frequently used in treating atopic dermatitis. Patients with severe skin lesions with immunosuppressants therapy may need further close-screening.
In conclusion, it should be recognized that atopic dermatitis is a potential risk factor for infective endocarditis, and further research is needed to evaluate and manage these risks.
References
1. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011; 242:233–246. PMID: 21682749.
2. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010; 125:4–13. PMID: 20109729.
3. Hauser C, Wuethrich B, Matter L, Wilhelm JA, Sonnabend W, Schopfer K. Staphylococcus aureus skin colonization in atopic dermatitis patients. Dermatologica. 1985; 170:35–39. PMID: 3972149.
4. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001; 345:1318–1330. PMID: 11794152.
5. Ahn K. The prevalence of atopic dermatitis in Korean children. Allergy Asthma Immunol Res. 2016; 8:1–2. PMID: 26540495.
6. Lee JH, Han KD, Kim KM, Park YG, Lee JY, Park YM. Prevalence of atopic dermatitis in Korean children based on data from the 2008-2011 Korean National Health and Nutrition Examination Survey. Allergy Asthma Immunol Res. 2016; 8:79–83. PMID: 26540505.
7. Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol. 1977; 113:780–782. PMID: 141239.
8. Patel D, Jahnke MN. Serious complications from Staphylococcal aureus in atopic dermatitis. Pediatr Dermatol. 2015; 32:792–796. PMID: 26337792.
9. Harada M, Nishi Y, Tamura S, Iba Y, Abe K, Yanbe Y, et al. [Infective endocarditis with a huge mitral vegetation related to atopic dermatitis and high serum level of infectionrelated antiphospholipid antibody: a case report]. J Cardiol. 2003; 42:135–140. PMID: 14526663.
10. Yamamoto T, Yodogawa K, Wakita S, Ogano M, Tokita M, Miyagi Y, et al. Recurrent prosthetic valve endocarditis caused by Staphylococcus aureus colonizing skin lesions in severe atopic dermatitis. Intern Med. 2007; 46:571–573. PMID: 17473491.
11. Grabczynska SA, Cerio R. Infective endocarditis associated with atopic eczema. Br J Dermatol. 1999; 140:1193–1194. PMID: 10354109.
12. Pike MG, Warner JO. Atopic dermatitis complicated by acute bacterial endocarditis. Acta Paediatr Scand. 1989; 78:463–464. PMID: 2741691.
13. Satchell AC, Barnetson RS. Staphylococcal septicaemia complicating treatment of atopic dermatitis with mycophenolate. Br J Dermatol. 2000; 143:202–203. PMID: 10886168.
14. Beneson S, Zimhony O, Dahan D, Solomon M, Raveh D, Schlesinger Y, et al. Atopic dermatitis--a risk factor for invasive Staphylococcus aureus infections: two cases and review. Am J Med. 2005; 118:1048–1051. PMID: 16164895.
15. Mohiyiddeen G, Brett I, Jude E. Infective endocarditis caused by Staphylococcus aureus in a patient with atopic dermatitis: a case report. J Med Case Rep. 2008; 2:143. PMID: 18454875.
16. Micallef MJ, Ramphul A. Infective endocarditis in a patient with atopic dermatitis. J Cardiol Cases. 2016; 13:153–154. PMID: 30546632.
17. Horimoto K, Kubo T, Matsusaka H, Baba H, Umesue M. Right-sided infective endocarditis with a ruptured sinus of Valsalva and multiple septic pulmonary emboli in a patient with atopic dermatitis. Intern Med. 2015; 54:797–800. PMID: 25832944.
18. Fukunaga N, Okada Y, Konishi Y, Murashita T, Koyama T. Pay attention to valvular disease in the presence of atopic dermatitis. Circ J. 2013; 77:1862–1866. PMID: 23535217.
19. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347:1151–1160. PMID: 12374875.
Table 1
Case | Author | Age (y)/gender | Underlying disease | Blood culture | Complication |
---|---|---|---|---|---|
1 | Yamamoto et al.10 | 27/M | Atopic dermatitis | MSSA | Mitral valve impairment |
2 | Grabczynska et al.11 | 24/M | Atopic dermatitis, cerebral palsy, asthma, deafness, previeous episodes of IE | MSSA | (-) |
3 | Pike et al.12 | 3/M | Atopic dermatitis, Ventricular septal defect, congenital immunodeficiency | Staphylococcus aureus | Tricuspid valve impairment |
4 | Satchell et al.13 | 50/F | Atopic dermatitis, asthma, allergic rhinitis | S. aureus | Mitral valve impairment |
5 | Beneson et al.14 | 36/F | Atopic dermatitis | MSSA | Mitral valve impairment |
6 | Beneson et al.14 | 17/M | Atopic dermatitis | MSSA | Septic arthritis of right shoulder |
7 | Mohiyiddeen et al.15 | 30/M | Atopic dermatitis, asthma | MSSA | Mitral valve impairment |
8 | Micallef et al.16 | 39/M | Atopic dermatitis, anxiety disorder | MSSA | Bacterial meningitis and mitral regurgitation |
9 | Horimoto et al.17 | 34/F | Atopic dermatitis | MSSA | Tricuspid valve impairement, multiple septic pulmonary emboli, and heart failure |
10 | Present case 1 | 22/M | Atopic dermatitis | MSSA | Cerebral infarction, splenic infarction, septic arthritis |
11 | Present case 2 | 42/F | Atopic dermatitis | MSSA | Cerebral infarction, acute pyelonephritis, splenic infarction |